NextPlat (NXPL) Depreciation & Amortization (CF) (2016 - 2026)
NextPlat's (NXPL) quarterly Depreciation & Amortization (CF) came in at $47000.0 in Q2 2026, down 68.67% year-over-year from $150000.0 in Q2 2025, and down 16.07% quarter-over-quarter from $56000.0 in Q1 2026.
Powered by 
Analysis
NextPlat (NXPL) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $47000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 68.67% year-over-year to $47000.0 in Q2 2026; TTM through Jun 2026 was $233000.0, a 53.21% decrease from a year earlier, with the FY2018 full-year figure at $263864.0, up 1.73% from the prior year.
- Depreciation & Amortization (CF) was $47000.0 for Q2 2026 at NextPlat, down from $56000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $196000.0 in Q3 2024 and troughed at $47000.0 in Q2 2026.
- A 3-year average of $121833.3 and a median of $140000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) sank 33.67% in 2025 and tumbled 68.67% in 2026, its largest moves.
- Over 3 years, Depreciation & Amortization (CF) stood at $196000.0 in 2024, then plunged by 33.67% to $130000.0 in 2025, then plunged by 63.85% to $47000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $47000.0 (Q2 2026), $56000.0 (Q1 2026), and $130000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 241.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 672.30 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 56.74 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 281.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 19.64 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 10.33 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 47,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47,000.00 |
| Mar 31, 2026 | 56,000.00 |
| Sep 30, 2025 | 130,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Mar 31, 2025 | 152,000.00 |
| Sep 30, 2024 | 196,000.00 |
| Jun 30, 2019 | 60,661.00 |
| Mar 31, 2019 | 60,965.00 |
| Dec 31, 2018 | 60,958.00 |
| Sep 30, 2018 | 68,693.00 |
| Jun 30, 2018 | 65,590.00 |
| Mar 31, 2018 | 69,023.00 |
| Dec 31, 2017 | 53,817.00 |
| Sep 30, 2017 | 67,893.00 |
| Jun 30, 2017 | 67,930.00 |
| Mar 31, 2017 | 69,728.00 |
| Dec 31, 2016 | 69,178.00 |
| Sep 30, 2016 | 63,969.00 |
| Jun 30, 2016 | 64,127.00 |
| Mar 31, 2016 | 69,529.00 |